GeneDx Holdings Corp. (WGS) stock analysis

WGS · GeneDx Holdings Corp.

Latest recorded price: USD 51.02

Sector and industry: Healthcare · Diagnostics & Research

Fiscal 2025 figures: revenue growth 22.1%, free cash flow margin 3.3%, ROIC -3.6%. The model flags 1 risk signal for this company.

Similar companies in Healthcare